miR-100 Inhibits Cell Growth and Proliferation by Targeting HOXA1 in Nasopharyngeal Carcinoma.

Weifeng HeYun HuangCheng Chuan JiangYuan ZhuLing WangWeiwei ZhangWeiguo HuangTing ZhouSanyuan Tang
Published in: OncoTargets and therapy (2020)
Taken together, our findings suggest that miR-100 could suppress NPC growth and proliferation through targeting HOXA1, providing a novel target for the miRNA-mediated therapy for patients with NPC in the future.